Sanofi India Ltd. Files SEBI Regulation 74(5) Certificate for Dec 2025 Quarter
Sanofi India Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The RTA, MUFG Intime India, confirmed the processing of dematerialisation requests and updates to the register of members.
This is a standard compliance filing required by SEBI regulations. It does not involve any new business developments, financial results, or strategic changes that would significantly affect the company's market position or stock performance.
The announcement is a routine regulatory filing regarding the processing of share certificates for dematerialisation and does not contain any material financial or operational information that would impact the company's stock positively or negatively.
Sanofi India Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate pertains to the period ending December 31, 2025.
The company's Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime India Private Limited), provided the enclosed certificate. This confirmation from the RTA indicates that securities received from depository participants for dematerialisation during the quarter ended December 31, 2025, were processed and confirmed to the depositories. Furthermore, the RTA confirmed that the security certificates received for dematerialisation were mutilated and cancelled after verification, and the depositories' names were substituted in the register of members within the stipulated timelines.
The company has requested that the stock exchanges, BSE Limited and the National Stock Exchange of India Limited, take this certificate on record.
What to do with a filing like this
Sanofi India Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanofi India Limited. Read the original for the full detail.